# Circulating miR-126 as a Novel Biomarker for Post Myocardial Infarction Remodeling

> **NCT01875484** · — · COMPLETED · sponsor: **Qilu Hospital of Shandong University** · enrollment: 1200 (actual)

## Conditions studied

- Myocardial Infarction
- Left Ventricular Remodeling
- miR-126

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01875484
- **Lead sponsor:** Qilu Hospital of Shandong University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2015-06
- **Final completion:** 2015-07
- **Target enrollment:** 1200 (ACTUAL)
- **Last updated:** 2015-07-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01875484

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01875484, "Circulating miR-126 as a Novel Biomarker for Post Myocardial Infarction Remodeling". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01875484. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*